106 related articles for article (PubMed ID: 9684575)
21. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of progressive multifocal leukoencephalopathy by computed tomography.
Carroll BA; Lane B; Norman D; Enzmann D
Radiology; 1977 Jan; 122(1):137-41. PubMed ID: 830323
[TBL] [Abstract][Full Text] [Related]
23. [Neuropathology of progressive multifocal leukoencephalopathy].
Murayama S; Saito Y
Brain Nerve; 2007 Feb; 59(2):119-24. PubMed ID: 17380776
[TBL] [Abstract][Full Text] [Related]
24. Neuro-ophthalmic findings in progressive multifocal leukoencephalopathy.
Wein F; Francis GS; Gans MS; Connolly WE; Burnier MN
Can J Ophthalmol; 1998 Aug; 33(5):270-5. PubMed ID: 9740956
[TBL] [Abstract][Full Text] [Related]
25. [Progressive multifocal leukoencephalopathy mimicking multiple sclerosis as the sole clinical manifestation of acquired immunodeficiency syndrome].
Dupuis M; Fernandes Xavier FG; Gonsette RE; Brucher JM
Acta Neurol Belg; 1986; 86(5):285-96. PubMed ID: 3811829
[TBL] [Abstract][Full Text] [Related]
26. Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Costa C; Martínez-Sáez E; Gutiérrez-Franco A; Eixarch H; Castro Z; Ortega-Aznar A; Ramón Y Cajal S; Montalban X; Espejo C
Mult Scler; 2015 Nov; 21(13):1632-43. PubMed ID: 26432853
[TBL] [Abstract][Full Text] [Related]
27. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
[TBL] [Abstract][Full Text] [Related]
28. Progressive multifocal leukoencephalopathy presenting as a single mass lesion.
Vanneste JA; Bellot SM; Stam FC
Eur Neurol; 1984; 23(2):113-8. PubMed ID: 6723712
[TBL] [Abstract][Full Text] [Related]
29. Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
Hoepner R; Kolb EM; Dahlhaus S; Hellwig K; Adams O; Kleiter I; Salmen A; Schneider R; Lukas C; Chan A; Berger JR; Gold R
Mult Scler; 2017 May; 23(6):830-835. PubMed ID: 27600113
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Baldwin KJ; Hogg JP
Curr Opin Neurol; 2013 Jun; 26(3):318-23. PubMed ID: 23493158
[TBL] [Abstract][Full Text] [Related]
31. PML: underdiagnosed in MS patients on natalizumab.
Steiner I
Lancet Neurol; 2010 Jun; 9(6):564; author reply 564-5. PubMed ID: 20494319
[No Abstract] [Full Text] [Related]
32. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis.
Kawamoto Y; Akiguchi I; Kovács GG; Flicker H; Budka H
Acta Neuropathol; 2004 Feb; 107(2):137-43. PubMed ID: 14605832
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Wattjes MP; Barkhof F
Curr Opin Neurol; 2014 Jun; 27(3):260-70. PubMed ID: 24739400
[TBL] [Abstract][Full Text] [Related]
34. Progressive multifocal leukoencephalopathy in an HTLV-I carrier.
Kimura A; Ueyama H; Kimura N; Fujimoto S; Kumamoto T
Clin Neurol Neurosurg; 2006 Dec; 108(8):768-71. PubMed ID: 16257112
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
White MK; Sariyer IK; Gordon J; Delbue S; Pietropaolo V; Berger JR; Khalili K
Rev Med Virol; 2016 Mar; 26(2):102-14. PubMed ID: 26663440
[TBL] [Abstract][Full Text] [Related]
36. L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Schwab N; Schneider-Hohendorf T; Posevitz V; Breuer J; Göbel K; Windhagen S; Brochet B; Vermersch P; Lebrun-Frenay C; Posevitz-Fejfár A; Capra R; Imberti L; Straeten V; Haas J; Wildemann B; Havla J; Kümpfel T; Meinl I; Niessen K; Goelz S; Kleinschnitz C; Warnke C; Buck D; Gold R; Kieseier BC; Meuth SG; Foley J; Chan A; Brassat D; Wiendl H
Neurology; 2013 Sep; 81(10):865-71. PubMed ID: 23925765
[TBL] [Abstract][Full Text] [Related]
37. Progressive multifocal leukoencephalopathy.
Brooks BR; Walker DL
Neurol Clin; 1984 May; 2(2):299-313. PubMed ID: 6503939
[TBL] [Abstract][Full Text] [Related]
38. Progressive multifocal leukoencephalopathy. Diagnosis by in situ hybridization with a biotinylated JC virus DNA probe using an automated Histomatic Code-On slide stainer.
Hulette CM; Downey BT; Burger PC
Am J Surg Pathol; 1991 Aug; 15(8):791-7. PubMed ID: 1648881
[TBL] [Abstract][Full Text] [Related]
39. Cortical demyelination in CNS inflammatory demyelinating diseases.
Lassmann H; Lucchinetti CF
Neurology; 2008 Jan; 70(5):332-3. PubMed ID: 18227414
[No Abstract] [Full Text] [Related]
40. Clinical-pathological conference.
Dehaene I; Cras P; Parizel PM; Martin JJ
Acta Neurol Belg; 1998 Mar; 98(1):41-8. PubMed ID: 9606440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
